Literature DB >> 24366667

Pore-exposed tyrosine residues of P-glycoprotein are important hydrogen-bonding partners for drugs.

Yaprak Dönmez Cakil1, Narakorn Khunweeraphong, Zahida Parveen, Diethart Schmid, Matthias Artaker, Gerhard F Ecker, Harald H Sitte, Oliver Pusch, Thomas Stockner, Peter Chiba.   

Abstract

The multispecific efflux transporter, P-glycoprotein, plays an important role in drug disposition. Substrate translocation occurs along the interface of its transmembrane domains. The rotational C2 symmetry of ATP-binding cassette transporters implies the existence of two symmetry-related sets of substrate-interacting amino acids. These sets are identical in homodimeric transporters, and remain evolutionary related in full transporters, such as P-glycoprotein, in which substrates bind preferentially, but nonexclusively, to one of two binding sites. We explored the role of pore-exposed tyrosines for hydrogen-bonding interactions with propafenone type ligands in their preferred binding site 2. Tyrosine 953 is shown to form hydrogen bonds not only with propafenone analogs, but also with the preferred site 1 substrate rhodamine123. Furthermore, an accessory role of tyrosine 950 for binding of selected propafenone analogs is demonstrated. The present study demonstrates the importance of domain interface tyrosine residues for interaction of small molecules with P-glycoprotein.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24366667      PMCID: PMC4503343          DOI: 10.1124/mol.113.088526

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  32 in total

1.  Quantification and characterization of P-glycoprotein-substrate interactions.

Authors:  Ewa Gatlik-Landwojtowicz; Päivi Aänismaa; Anna Seelig
Journal:  Biochemistry       Date:  2006-03-07       Impact factor: 3.162

2.  Tyrosine hydrogen bonds make a large contribution to protein stability.

Authors:  C N Pace; G Horn; E J Hebert; J Bechert; K Shaw; L Urbanikova; J M Scholtz; J Sevcik
Journal:  J Mol Biol       Date:  2001-09-14       Impact factor: 5.469

3.  A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.

Authors:  Jason Moffat; Dorre A Grueneberg; Xiaoping Yang; So Young Kim; Angela M Kloepfer; Gregory Hinkle; Bruno Piqani; Thomas M Eisenhaure; Biao Luo; Jennifer K Grenier; Anne E Carpenter; Shi Yin Foo; Sheila A Stewart; Brent R Stockwell; Nir Hacohen; William C Hahn; Eric S Lander; David M Sabatini; David E Root
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

4.  Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity.

Authors:  K Ito; C J Oleschuk; C Westlake; M Z Vasa; R G Deeley; S P Cole
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

5.  Data-driven homology modelling of P-glycoprotein in the ATP-bound state indicates flexibility of the transmembrane domains.

Authors:  Thomas Stockner; Sjoerd J de Vries; Alexandre M J J Bonvin; Gerhard F Ecker; Peter Chiba
Journal:  FEBS J       Date:  2009-02       Impact factor: 5.542

Review 6.  Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1.

Authors:  Daniel A P Gutmann; Andrew Ward; Ina L Urbatsch; Geoffrey Chang; Hendrik W van Veen
Journal:  Trends Biochem Sci       Date:  2009-10-12       Impact factor: 13.807

7.  Partitioning of amino acid side chains into lipid bilayers: results from computer simulations and comparison to experiment.

Authors:  Justin L MacCallum; W F Drew Bennett; D Peter Tieleman
Journal:  J Gen Physiol       Date:  2007-04-16       Impact factor: 4.086

8.  P-glycoprotein substrate binding domains are located at the transmembrane domain/transmembrane domain interfaces: a combined photoaffinity labeling-protein homology modeling approach.

Authors:  Karin Pleban; Stephan Kopp; Edina Csaszar; Michael Peer; Thomas Hrebicek; Andreas Rizzi; Gerhard F Ecker; Peter Chiba
Journal:  Mol Pharmacol       Date:  2004-10-27       Impact factor: 4.436

9.  Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans.

Authors:  Mi Sun Jin; Michael L Oldham; Qiuju Zhang; Jue Chen
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

10.  Functional analyses reveal an important role for tyrosine residues in the staphylococcal multidrug efflux protein QacA.

Authors:  Jingqin Wu; Karl A Hassan; Ronald A Skurray; Melissa H Brown
Journal:  BMC Microbiol       Date:  2008-09-16       Impact factor: 3.605

View more
  14 in total

Review 1.  Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies.

Authors:  Eduardo E Chufan; Hong-May Sim; Suresh V Ambudkar
Journal:  Adv Cancer Res       Date:  2015-01-08       Impact factor: 6.242

2.  Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1).

Authors:  Biebele Abel; Dilip K Tosh; Stewart R Durell; Megumi Murakami; Shahrooz Vahedi; Kenneth A Jacobson; Suresh V Ambudkar
Journal:  Mol Pharmacol       Date:  2019-05-24       Impact factor: 4.436

3.  Molecular Mechanism of Taurocholate Transport by the Bile Salt Export Pump, an ABC Transporter Associated with Intrahepatic Cholestasis.

Authors:  Muhammad Imran Sohail; Diethart Schmid; Katrin Wlcek; Matthias Spork; Gergely Szakács; Michael Trauner; Thomas Stockner; Peter Chiba
Journal:  Mol Pharmacol       Date:  2017-08-07       Impact factor: 4.436

4.  Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.

Authors:  Eduardo E Chufan; Khyati Kapoor; Suresh V Ambudkar
Journal:  Biochem Pharmacol       Date:  2015-12-11       Impact factor: 5.858

5.  In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin.

Authors:  Bihter Atil; Evelyn Berger-Sieczkowski; Johanna Bardy; Martin Werner; Martin Hohenegger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-30       Impact factor: 3.000

6.  Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein.

Authors:  Szabolcs Tarapcsák; Gábor Szalóki; Ágnes Telbisz; Zsuzsanna Gyöngy; Krisztina Matúz; Éva Csősz; Péter Nagy; Imre J Holb; Ralph Rühl; László Nagy; Gábor Szabó; Katalin Goda
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

7.  Folding correction of ABC-transporter ABCB1 by pharmacological chaperones: a mechanistic concept.

Authors:  Matthias Spork; Muhammad Imran Sohail; Diethart Schmid; Gerhard F Ecker; Michael Freissmuth; Peter Chiba; Thomas Stockner
Journal:  Pharmacol Res Perspect       Date:  2017-05-26

Review 8.  Comparison of mechanistic transport cycle models of ABC exporters.

Authors:  Dániel Szöllősi; Dania Rose-Sperling; Ute A Hellmich; Thomas Stockner
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-10-31       Impact factor: 3.747

9.  The ABCG2 multidrug transporter is a pump gated by a valve and an extracellular lid.

Authors:  Narakorn Khunweeraphong; Daniel Szöllősi; Thomas Stockner; Karl Kuchler
Journal:  Nat Commun       Date:  2019-11-28       Impact factor: 14.919

10.  Active transport of rhodamine 123 by the human multidrug transporter P-glycoprotein involves two independent outer gates.

Authors:  Fauzia Nasim; Diethart Schmid; Gergely Szakács; Azmat Sohail; Harald H Sitte; Peter Chiba; Thomas Stockner
Journal:  Pharmacol Res Perspect       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.